Status:
UNKNOWN
Noninvasive Chromosomal Screening for Embryo Selection Trial
Lead Sponsor:
Olive Fertility Centre
Collaborating Sponsors:
Thermo Fisher Scientific, Inc
Sequence46
Conditions:
Infertility
Aneuploidy
Eligibility:
All Genders
21-35 years
Brief Summary
To determine the diagnostic accuracy of non-invasive preimplantation genetic testing for aneuploidy (NI-PGT-A) for embryo selection.
Detailed Description
Hypothesis: Analysis of cell free DNA (cfDNA) released from developing embryos into spent culture media (SCM) can serve as a non-invasive method for performing preimplantation genetic testing for ane...
Eligibility Criteria
Inclusion
- Patient undergoing IVF-ICSI at the Olive Fertility Centre
- 21 - 35 years old at the time of enrolment
- Elective freeze-all cycle
- Planning for single embryo transfer
Exclusion
- Undergoing PGT-A, PGT-SR, PGT-M
- History of recurrent pregnancy loss
- History of recurrent implantation failure
- Planning on transfer of more than 1 embryo
Key Trial Info
Start Date :
December 4 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 4 2022
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04732013
Start Date
December 4 2020
End Date
December 4 2022
Last Update
April 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Olive Fertility Centre
Vancouver, British Columbia, Canada, V6R1L4